What zanubrutinib does

Zanubrutinib is a BTK inhibitor that treats blood cancers like leukemia and lymphoma by stopping B-cell growth and survival. It blocks signaling pathways that allow cancer cells to spread.

Why supportive care matters

Zanubrutinib alone isn't enough. Effective treatment requires coordinated monitoring, timely detection of changes, and adjustments based on how your body responds over the long term.

Monitor blood counts regularly

Regular blood tests track cell levels and catch problems before they become serious. Changes in results guide dose adjustments and additional supportive measures. Report fatigue, bruising, or fever immediately.

“Anemia is pretty widespread.”

Watch your heart health

Zanubrutinib can cause cardiac arrhythmias like atrial fibrillation. Monitor for rapid or irregular heartbeat, dizziness, shortness of breath, and chest discomfort. Blood pressure checks are also essential.

Check for drug interactions

Zanubrutinib interacts with many medicines, supplements, and herbal products. Tell your doctor about everything you take, including over-the-counter items, before starting or stopping any medication.

Protect your liver

Liver function tests are done before and during treatment. Report abdominal discomfort, dark urine, or yellowing skin or eyes. Tell your doctor if you have liver disease or hepatitis B.

Reduce bleeding risk

Zanubrutinib affects platelets, increasing bleeding risk. Avoid blood thinners when possible, use sun protection, and report blood in urine or stool, vomiting blood, or severe bruising immediately.

Protect your skin

Reduce ultraviolet exposure by using sunscreen and protective clothing. Report any persistent or unusual skin changes to your healthcare provider right away.

Coordinated care is key

Your cancer team must work with other specialists to manage side effects and prevent serious complications. Regular lab tests, medication reviews, and open communication ensure the best outcomes.

“Personalized and Coordinated Care Is Essential”